Skip to main content
Dan Krakoff

Dan Krakoff

Partner and Chair of the Global Life Sciences Industry Practice at Arnold & Porter

Aug 3, 2026

13:49
Your impression.
13:51
Um, I agree with Gayatri in terms of the chaos, uh, that's occurred.
13:57
Um, I mean, we've had five acting or, or actual CBER directors and six CDER directors in a relatively short period of time.
14:08
We have some people in place now that are a lot more typical in terms of what we've seen in the past, um, uh, and some folks who are in place now that seem to be seeking a reset, uh, a regular order at least, um, a type of tenor to FDA.
14:31
I just worry, is it gonna la-last past the midterm elections? Uh, because, you know, RFK Jr., secretary, has his views of the world.
14:42
Um, uh, they were, you know, quite active in implementing those views, uh, through, um, the prior, um, commissioner and head of CBER and others.
14:55
Um, and it-- we could easily go back to a state of chaos, and I think it's really important, um, that they at least recognize that there's a political liability to allowing FDA to lose its authority, uh, and, uh, you know, uh, really put FDA in the public eye.

16 MINS LATER

31:40
Uh, what's your view as to what's going on now, and especially what's happened in the last 18 months, uh, with this new administration?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.